首页> 美国卫生研究院文献>Current Chemical Genomics and Translational Medicine >A Homogenous Luminescent Proximity Assay for 14-3-3 Interactions with Both Phosphorylated and Nonphosphorylated Client Peptides
【2h】

A Homogenous Luminescent Proximity Assay for 14-3-3 Interactions with Both Phosphorylated and Nonphosphorylated Client Peptides

机译:14-3-3与磷酸化和非磷酸化客户肽相互作用的同质发光法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 14-3-3 proteins are a family of dimeric eukaryotic proteins that mediate both phosphorylation-dependent and -independent protein-protein interactions. Through these interactions, 14-3-3 proteins participate in the regulation of a wide range of cellular processes, including cell proliferation, cell cycle progression, and apoptosis. Because of their fundamental importance, 14-3-3 proteins have also been implicated in a variety of diseases, including cancer and neurodegenerative disorders. In order to monitor 14-3-3/client protein interactions for the discovery of small molecule 14-3-3 modulators, we have designed and optimized 14-3-3 protein binding assays based on the amplified luminescent proximity homogeneous assay (AlphaScreen) technology. Using the interaction of 14-3-3 with a phosphorylated Raf-1 peptide and a nonphosphorylated R18 peptide as model systems, we have established homogenous “add-and-measure” high-throughput screening assays. Both assays achieved robust performance with S/B ratios above 7 and Z’ factors above 0.7. Application of the known antagonistic peptides in our studies further validated the assay for screening of chemical compound libraries to identify small molecules that can modulate 14-3-3 protein-protein interactions.
机译:14-3-3蛋白是二聚体真核蛋白家族,其介导磷酸化依赖性蛋白和蛋白质依赖性蛋白相互作用。通过这些相互作用,14-3-3蛋白参与了广泛的细胞过程的调控,包括细胞增殖,细胞周期进程和凋亡。由于它们的根本重要性,14-3-3蛋白还涉及多种疾病,包括癌症和神经退行性疾病。为了监视14-3-3 /客户蛋白质相互作用以发现小分子14-3-3调节剂,我们基于扩增的发光邻近均质测定(AlphaScreen)设计并优化了14-3-3蛋白结合测定技术。使用14-3-3与磷酸化的Raf-1肽和非磷酸化的R18肽的相互作用作为模型系统,我们建立了均一的“添加并测量”高通量筛选分析方法。两种测定均实现了强大的性能,S / B比大于7,Z'因子大于0.7。已知拮抗肽在我们研究中的应用进一步验证了筛选化合物库的方法,以鉴定可调节14-3-3蛋白质-蛋白质相互作用的小分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号